Quality indicators for the care of breast cancer in vulnerable elders.
Naeim
Arash
A
David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA. anaeim@mednet.ucla.edu
Sawhney
Rishi
R
MacLean
Catherine H
CH
Sanati
Homayoon
H
D000368:Aged; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000175:diagnosis / Q000556:secondary / Q000628:therapy; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy*; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy; D018275:Carcinoma, Lobular / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D015897:Comorbidity; D004164:Diphosphonates / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D005260:Female; D016330:Frail Elderly; D006801:Humans; D008207:Lymphatic Metastasis; D008327:Mammography; D008408:Mastectomy; D009367:Neoplasm Staging; D017064:Process Assessment, Health Care; D019984:Quality Indicators, Health Care; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism
D047072:Aromatase Inhibitors; D004164:Diphosphonates; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone